Novo Plunges After “Lottery Ticket” Alzheimer’s GLP-1 Study Fails
HEALTHCARE
Zepbound to the Moon: Eli Lilly Joins the Trillionaire Club
HEALTHCARE
Novo’s Slim-Down Strategy Taps Cheaper Wegovy To Keep It On Top
PHARMA
Switzerland Nears Trump Tariff Truce at 15%
TRADE
Novo’s India Play: A Second Name For The Same Shot
PHARMA
Trump Is Making Skinny Drugs Cheaper
AI
Kimberly-Clark to Buy Tylenol’s Chaos for $48.7 Billion
CONSUMER
Ireland’s GDP Trips Over Tariff Drama
AI
Cigna Finally Notices Everyone Hates Drug Prices
HEALTH CARE
Kering’s Beauty Exit Blushes L’Oréal
FASHION
Amazon & One Medical May Have a Cure for America’s Coming Premium Shock
HEALTH CARE
Merck Begins Next Act As Chip Guy Takes the Helm
PHARMA
Trump White House Strikes “Discount” Deal With Pfizer
PHARMACEUTICALS
AstraZeneca Takes Wall Street Detour While Keeping London Address
PHARMA
Trump’s Pharma Tariffs Leave Europe With a Headache
PHARMA
Tylenol Survives Trump as Science Prevails
PHARMA
Pfizer Finally Buys Its Way Into Ozempicland
PHARMA
Novo’s Wegovy Pill Lands A Heavyweight Punch
PHARMA
Pfizer, Moderna Crater as Trump Officials Link Covid to Child Deaths
VACCINES
Novo Nordisk Sheds Some Weight, Cuts 9,000 Jobs
PHARMA
Convatec’s $300M Buyback Puts the Bandages on Investor Wounds
HEALTHCARE
Novo Nordisk Stock Swells as It Slashes Ozempic Prices
PHARMA
Novo Nordisk Dances on Lilly’s Experimental Weight-Loss Pill Misses
GLP-1
Europe Big Pharma Gets Trumped Again With 250% Tariff Bombshell
PHARMA